SAJAZIR (icatibant): a portable, subcutaneous treatment,1 within easy reach*
*SAJAZIR injection is a prefilled syringe for subcutaneous use.1 Patients should not inject SAJAZIR until they have been trained by a Cycle Vita product support nurse or their healthcare provider.
SAJAZIR (Icatibant) injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.1
SAJAZIR is a prefilled, self-administered, subcutaneous injection to treat acute HAE attacks, that can be used as soon as your patients recognize the symptoms of an attack.1
Storing SAJAZIR1
- SAJAZIR may be stored at room temperature. Store between 36°F and 77°F (2°C and 25°C)
Administering SAJAZIR1
- Requires no reconstitution/mixing, no dose calculation, no special handling, no dose titration, and no refrigeration
- Do not administer if the product contains particulates or is discolored
- SAJAZIR is administered over at least 30 seconds into the abdominal area
- Patients may subcutaneously self-administer SAJAZIR upon recognition of symptoms of an HAE attack, after training by a healthcare provider
Access Full Instructions for Use (IFU) here.
Dosing1
- SAJAZIR is available as a 3 mL, prefilled, single-use syringe (30 mg)
- If response is inadequate or symptoms recur, additional doses of SAJAZIR may be administered at intervals of 6 hours or longer
- No more than 3 doses may be used in a 24-hour period
- SAJAZIR is available in a convenient pack containing 3 cartons
- Single cartons are also available
Reference
- SAJAZIR™ (icatibant) Injection. Prescribing Information. Cycle Pharmaceuticals Limited.